Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Team Grant: Chronic Disease Risk and Intervention Strategies - LOI

University of Toronto

$9,939.00

Environmental Air Pollution, Airway Injury and Repair: Understanding the Pathogenetic Relationship to Improve Health Outcome

FY 2010-11

Summary
Environmental air pollution (EAP) is known to cause disease and increase death from respiratory and cardiac diseases. The airways are particularly vulnerable as each breath results in contact with EAP. Patients with chronic airway diseases such as asthma, chronic obstructive lung disease and patients following lung transplant can have worsening of their disease, and lose lung function as a result of EAP exposure. The mechanisms that link EAP to airway diseases are not well understood. Studies suggest that chronic airway diseases share common features: 1. airway inflammation and injury and 2. abnormal repair that lead to changes in the airway structure and interfere with normal function. Our research will assess the effects of EAP on cells, animals and people. This allows us to identify culprit cellular mechanisms, test potential interventions such as drugs in animals (to evaluate safety before moving to clinical trials) and study relevant clinical outcomes in different patient populations. Our research is unique in several ways: 1. study of lung transplant recipients, a unique group of patients followed closely by the Toronto Lung Transplant program, one of the most active programs in the world, 2. study of patients with asthma in a controlled setting of air pollution that simulates 'real-life' exposure levels, 3. the ability to compare findings in a common disease (asthma) to a select but well-characterized group (lung transplant recipients) to look for common mechanisms, and lastly 4. inclusion of engineers and state-of-the-art instruments that allow us to accurately measure pollution exposures and characterize specific pollutants. Our team also includes government scientists from Environment Canada and the Ontario Agency for Health Protection and Promotion. This will facilitate rapid dissemination of our findings to government to develop better health and public policies that will mitigate the harmful effects of pollution.
Program
Team Grant: Chronic Disease Risk and Intervention Strategies - LOI
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
230226
Name
Chow Chung-Wai
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Team Grant: Chronic Disease Risk and Intervention Strategies - LOI
Projecttitle
Environmental Air Pollution, Airway Injury and Repair: Understanding the Pathogenetic Relationship to Improve Health Outcome
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$9,939
Cihrequipment2
$0
Programname2
Team Grant: Chronic Disease Risk and Intervention Strategies - LOI
Keyworddelim
Airway Inflammation; Airway Repair; Asthma; Cell Culture Models; Clinical Studies; Environmental Air Pollution; Human Exposures; Lung Transplantation; Mouse Models; Publich Policy
Abstract
Environmental air pollution (EAP) is known to cause disease and increase death from respiratory and cardiac diseases. The airways are particularly vulnerable as each breath results in contact with EAP. Patients with chronic airway diseases such as asthma, chronic obstructive lung disease and patients following lung transplant can have worsening of their disease, and lose lung function as a result of EAP exposure. The mechanisms that link EAP to airway diseases are not well understood. Studies suggest that chronic airway diseases share common features: 1. airway inflammation and injury and 2. abnormal repair that lead to changes in the airway structure and interfere with normal function. Our research will assess the effects of EAP on cells, animals and people. This allows us to identify culprit cellular mechanisms, test potential interventions such as drugs in animals (to evaluate safety before moving to clinical trials) and study relevant clinical outcomes in different patient populations. Our research is unique in several ways: 1. study of lung transplant recipients, a unique group of patients followed closely by the Toronto Lung Transplant program, one of the most active programs in the world, 2. study of patients with asthma in a controlled setting of air pollution that simulates 'real-life' exposure levels, 3. the ability to compare findings in a common disease (asthma) to a select but well-characterized group (lung transplant recipients) to look for common mechanisms, and lastly 4. inclusion of engineers and state-of-the-art instruments that allow us to accurately measure pollution exposures and characterize specific pollutants. Our team also includes government scientists from Environment Canada and the Ontario Agency for Health Protection and Promotion. This will facilitate rapid dissemination of our findings to government to develop better health and public policies that will mitigate the harmful effects of pollution.
Competitiondate
201103
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chow, Chung-Wai
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $9,939~ $0~